PHARMACYCLICS INC's ticker is PCYC and the CUSIP is 716933106. A total of 1 filers reported holding PHARMACYCLICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2015 | $4,181,000 | -26.7% | 16,334 | -65.0% | 0.03% | -27.7% |
Q4 2014 | $5,702,000 | +165.1% | 46,640 | +154.6% | 0.05% | +161.1% |
Q3 2014 | $2,151,000 | +30.8% | 18,317 | -0.1% | 0.02% | +28.6% |
Q2 2014 | $1,645,000 | -10.2% | 18,336 | +0.3% | 0.01% | -12.5% |
Q1 2014 | $1,832,000 | -5.3% | 18,280 | -0.0% | 0.02% | -5.9% |
Q4 2013 | $1,935,000 | -23.4% | 18,288 | +0.2% | 0.02% | -26.1% |
Q3 2013 | $2,527,000 | +74.0% | 18,254 | -0.1% | 0.02% | +64.3% |
Q2 2013 | $1,452,000 | – | 18,277 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 9,129,231 | $1,116,140,000 | 11.39% |
DAFNA Capital Management LLC | 110,928 | $13,562,000 | 10.73% |
HWG Holdings LP | 107,389 | $13,129,000 | 9.36% |
Opaleye Management Inc. | 85,000 | $10,392,000 | 5.25% |
Opus Point Partners Management, LLC | 25,723 | $3,145,000 | 3.11% |
BB BIOTECH AG | 731,542 | $89,438,000 | 2.90% |
Peregrine Asset Advisers, Inc. | 33,375 | $4,080,000 | 2.87% |
HARVEY CAPITAL MANAGEMENT INC | 54,770 | $6,696,000 | 2.57% |
Parametric Risk Advisors LLC | 300,000 | $36,678,000 | 2.45% |
BENDER ROBERT & ASSOCIATES | 28,619 | $3,499,000 | 2.29% |